Sign In To Continue
You have reached the guest article limit.
Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.
Patent licensing companies are increasingly using a dual litigation strategy involving both the Unified Patent Court (UPC) in Europe and the United States courts. This approach aims to maximize their leverage in paten...
Share This Article
Ready-to-post copy includes the article link.
Biopharma Companies Embrace Dual UPC and US Litigation Strategy Patent licensing companies are increasingly using a dual litigation strategy involving both the Unified Patent Court (UPC) in Europe and the United States courts. This approach aims to maximize their leverage in paten... Read the full IIPLA article: https://iipla.org/news/biopharma-companies-embrace-dual-upc-and-us-litigation-strategy